MARKET

BRTX

BRTX

Biorestorative Therapies Inc
NASDAQ
0.2700
+0.0030
+1.12%
After Hours: 0.2680 -0.002 -0.74% 19:59 02/18 EST
OPEN
0.2670
PREV CLOSE
0.2670
HIGH
0.2900
LOW
0.2580
VOLUME
7.22M
TURNOVER
--
52 WEEK HIGH
2.380
52 WEEK LOW
0.2194
MARKET CAP
2.44M
P/E (TTM)
-0.1827
1D
5D
1M
3M
1Y
5Y
1D
BioRestorative Therapies Announces $5 Million Offering With Warrants Issued
Reuters · 1d ago
Weekly Report: what happened at BRTX last week (0209-0213)?
Weekly Report · 2d ago
BioRestorative Therapies Raises $5 Million in Public Offering with Warrants Exercisable at $0.35
Reuters · 5d ago
BIORESTORATIVE ANNOUNCES CLOSING OF $5.0 MILLION PUBLIC OFFERING
Reuters · 5d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 5d ago
S&P 500 Falls Over 1%; American Electric Power Shares Gain After Upbeat Earnings
Benzinga · 6d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 6d ago
Dow Jumps Over 200 Points; US Initial Jobless Claims Fall
Benzinga · 6d ago
More
About BRTX
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.

Webull offers BioRestorative Therapies Inc stock information, including NASDAQ: BRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRTX stock methods without spending real money on the virtual paper trading platform.